the aid library

LIST OPTIONS

Filter

8569

Pandemic influenza preparedness framework: partnership contribution high-level implementation plan III 2024-2030

World Health Organization WHO (2023) C_WHO

The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t... more

Download (143)

View PDF (171)

Interruption of transmission and elimination of leprosy disease - Technical guidance

World Health Organisation (WHO) (2023) C_WHO

This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p... more

Download (154)

View PDF (158)

Leprosy Programme and Transmission Assessment

World Health Organisation (WHO) (2023) C_WHO

The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i.... more

External Link

Assessing Development Assistance for Mental Health in Developing Countries: 2007–2013

Gilbert, B.J.; V. Patel; P. E. Farmer et al. PLoS Med (2015) CC

Mental disorders are a leading cause of the global burden of disease, and the provision of mental health services in developing countries remains very limited and far from equitable. Using the Creditor Reporting System, we estimate the amounts and patterns of development assistance for global mental... more

Download (101)

View PDF (118)

Draft Proposed programme budget 2022–2023: Building forward better

World Health Organization (WHO) World Health Organization (WHO) (2021) CC

The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Ready to Use Therapeutic Food (RUFT) and the WHO Essential Medicines List

CMAM Forum (2018) CC

Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist yet sadly approximately only 3.2 million children with SAM have access to treatme... more

Time to align: development cooperation for the prevention and control of non-communicable diseases

Collins, T.E.; Nugent, R.; Webb, D.; et al. The British Medical Journal (BMJ) (2019) CC2

The article "Time to Align: Development Cooperation for the Prevention and Control of Non-Communicable Diseases" argues for greater international cooperation and investment in addressing non-communicable diseases (NCDs), especially in low- and middle-income countries. Traditionally, global health fu... more

Prélèvement avec Vacutainer® dans le contexte de suspicion d’infection à virus Ebola

Odile Ouwe Missi Oukem‐Boyer CERMES (2014)

Download (191)

View PDF (283)

Factsheet about tick-borne encephalitis (TBE)

European Centre for Disease Prevention and Control (2019) C2

Accessed: 11.03.2019

COVID-19: Health Emergency Preparedness Simulation Exercise

World Health Organisation (WHO) Health Emergencies Programme (2020) C_WHO

General Objectives 1. Share information on the progress of your preparation, including response capabilities, plans and procedures to identify and respond to an imported case of COVID-19 in your country. 2. Identify areas of interdependence between health actors and other sectors 3. Conduct g... more

COVID-19: Exercise de simulation pour la Préparation à une Urgence sanitaire

World Health Organisation (WHO) Health Emergencies Programme (2020) C_WHO

Objectifs généraux 1. Partager des informations sur l'avancement de la préparation, y compris les capacités de réponse, les plans et les procédures pour identifier et répondre à des cas de COVID-19 dans votre pays. 2. Identifier les domaines d'interdépendance entre les acteurs de la san... more

External Link

Surgical approaches to the urogenital manifestations of lymphatic filariasis

World Health Organization WHO (2019) C_WHO

During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc... more

Download (2043)

View PDF (5000)

WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage
recommended

World Health Organization WHO (2012) C_WHO

To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH

Health Cluster Guide

World Health Organization, IASC (2020) CC

A practical handbook. This Health Cluster Guide (2nd edition, 2020) provides practical advice on how WHO, Health Cluster Coordinators and partners can work together during a humanitarian crisis to achieve the aims of reducing avoidable mortality, morbidity and disability, and restoring the delivery ... more

Download (1101)

View PDF (1735)

Basic Newborn Resuscitation: A Practical Guide

World Health Organization Word Health Organization (1997) C_WHO

Safe Motherhood Series

Download (1561)

View PDF (2613)

Neonatal Tetanus Elimination Field Guide

Pan American Health Organisation PAHO (2005) C_WHO

In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal tetanus in the Americas. Neonatal tetanus is prevent... more

Download (1342)

View PDF (2305)

Immunization Essentials a practical Field Guide

USAID USAID (2004) CC

This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc... more

Download (2311)

View PDF (1301)

Food Security Program Lifecycle Toolkit

Food for the Hungry (2006) CC

It is our hope and prayer that the guidance and multiple tools provided herein to manage the entire lifecycle of a food security program are useful to our food security staff, our local partners, and our fellow international Cooperating Sponsors throughout the world.

Download (1085)

View PDF (1777)

Clinical Management Rape Survivors Developing Protocols

World Health Organization; UNHCR (2004) C_WHO

Developing protocols for use with refugees and internally displaced persons

WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage recommended

WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage
recommended